Annals of Surgery · 1990 · 45 citations · 9 references
MedicineNeurological SurgerySurgeryCardiovascular PharmacotherapyVascular SurgeryAntiplatelet TherapyAntithrombotic TherapyCarotid Artery DiseaseCarotid Artery SurgeryCarotid EndarterectomyThrombosisAntiplatelet DrugsCarotid Artery Disease PharmacotherapyPeriprocedural Antiplatelet Therapy
To examine the role of antiplatelet drugs in the secondary prevention of arteriosclerotic arterial disease following carotid endarterectomy, a clinical series (n = 252) was analyzed. Based on these results a prospective randomized trial was initiated, comparing the effect of antiplatelet drugs (acetyl-salicylic acid [ASA] 1000 mg/day) versus untreated controls. In both investigations patient survival was the primary end point. A cardiac risk (n = 91) implied a significant reduction in patient survival (p less than 0.019 Breslow, p less than 0.052 Mantel). Antiaggregating drugs prolonged survival in the collective series (p less than 0.0001 Breslow, p less than 0.0002 Mantel) and in the subgroup of patients with cardiac risk (p less than 0.014 Breslow, p less than 0.020 Mantel) as well. In the prospective trial 66 patients were recruited, receiving ASA (n = 32) versus no therapy (n = 34). During follow-up 15 patients died, 4 in the treatment, and 11 in the control group. Between both groups there was a significant difference in the probability of survival (p less than 0.021 Breslow, p less than 0.048 Mantel).
9
Randomised trial of prophylactic daily aspirin in British male doctors
Richard Peto, Richard Gray, R Collins et al. · BMJ · 1988 · 1.2K citations · Full text
Predisposition to Atherosclerosis in the Head, Heart, and Legs
Tavia Gordon · JAMA · 1972 · 344 citations
Carotid Endarterectomy for Cerebrovascular Insufficiency
Jesse E. Thompson, Dale J. Austin, R. Don Patman · Annals of Surgery · 1970 · 291 citations · Full text
Medicine, Neurosurgery, Surgery +14